1
|
Li H, Qian Z, Liu Z, Liu X, Han X and Kang
H: Risk factors and outcome of acute renal failure in patients with
severe acute pancreatitis. J Crit Care. 25:225–229. 2010.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Papachristou GI, Clermont G, Sharma A,
Yadav D and Whitcomb DC: Risk and markers of severe acute
pancreatitis. Gastroenterol Clin North Am. 36:277–296, viii. 2007.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Zhang XP, Wang L and Zhou YF: The
pathogenic mechanism of severe acute pancreatitis complicated with
renal injury: A review of current knowledge. Digest Dis Sci. 53:pp.
297–306. 2008; View Article : Google Scholar : PubMed/NCBI
|
4
|
Zhu AJ, Shi JS and Sun XJ: Organ failure
associated with severe acute pancreatitis. World J Gastroentero.
9:2570–2573. 2003.
|
5
|
Rawlings JS, Rosler KM and Harrison DA:
The JAK/STAT signaling pathway. J Cell Sci. 117:1281–1283. 2004.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Yang X, He G, Hao Y, Chen C, Li M, Wang Y,
Zhang G and Yu Z: The role of the JAK2-STAT3 pathway in
pro-inflammatory responses of EMF-stimulated N9 microglial cells. J
Neuroinflammation. 7:542010. View Article : Google Scholar : PubMed/NCBI
|
7
|
Yu JH and Kim H: Role of janus
kinase/signal transducers and activators of transcription in the
pathogenesis of pancreatitis and pancreatic cancer. Gut Liver.
6:417–422. 2012. View Article : Google Scholar : PubMed/NCBI
|
8
|
Vona-Davis LC, Frankenberry KA, Waheed U,
Peterson E and McFadden DW: Expression of STAT3 and SOCS3 in
pancreatic acinar cells 1,2. J Surg Res. 127:14–20. 2005.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Ju KD, Lim JW, Kim KH and Kim H: Potential
role of NADPH oxidase-mediated activation of Jak2/Stat3 and
mitogen-activated protein kinases and expression of TGF-β1 in the
pathophysiology of acute pancreatitis. Inflamm Res. 60:791–800.
2011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Horiguchi A and Asano T, Kuroda K, Sato A,
Asakuma J, Ito K, Hayakawa M, Sumitomo M and Asano T: STAT3
inhibitor WP1066 as a novel therapeutic agent for renal cell
carcinoma. Brit J Cancer. 102:1592–1599. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Brands MW, Banes-Berceli AK, Inscho EW,
Al-Azawi H, Allen AJ and Labazi H: Interleukin 6 knockout prevents
angiotensin II hypertension: role of renal vasoconstriction and
janus kinase 2/signal transducer and activator of transcription 3
activation. Hypertension. 56:879–884. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Pang M, Ma L, Gong R, Tolbert E, Mao H,
Ponnusamy M, Chin YE, Yan H, Dworkin LD and Zhuang S: A novel STAT3
inhibitor, S3I-201, attenuates renal interstitial fibroblast
activation and interstitial fibrosis in obstructive nephropathy.
Kidney Int. 78:257–268. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Aggarwal BB and Harikumar KB: Potential
therapeutic effects of curcumin, the anti-inflammatory agent,
against neurodegenerative, cardiovascular, pulmonary, metabolic,
autoimmune, and neoplastic diseases. Int J Biochem Cell Biol.
41:40–59. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Wang ME, Chen YC, Chen IS, Hsieh SC, Chen
SS and Chiu CH: Curcumin protects against thioacetamide-induced
hepatic fibrosis by attenuating the inflammatory response and
inducing apoptosis of damaged hepatocytes. J Nutr Biochem.
23:1352–1366. 2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Mun SH, Joung DK, Kim YS, Kang OH, Kim SB,
Seo YS, Kim YC, Lee DS, Shin DW, Kweon KT and Kwon DY: Synergistic
antibacterial effect of curcumin against methicillin-resistant
Staphylococcus aureus. Phytomedicine. 20:714–718. 2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Kim BH, Lee ES, Choi R, Nawaboot J, Lee
MY, Lee EY, Kim HS and Chung CH: Protective effects of curcumin on
renal oxidative stress and lipid metabolism in a rat model of Type
2 diabetic nephropathy. Yonsei Med J. 57:664–673. 2016. View Article : Google Scholar : PubMed/NCBI
|
17
|
Trujillo J, Chirino YI, Molina-Jijón E,
Andérica-Romero AC, Tapia E and Pedraza-Chaverrí J: Renoprotective
effect of the antioxidant curcumin: Recent findings. Redox Biol.
1:448–456. 2013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Karahan MA, Yalcin S, Aydogan H,
Büyükfirat E, Kücük A, Kocarslan S, Yüce HH, Taskın A and Aksoy N:
Curcumin and dexmedetomidine prevents oxidative stress and renal
injury in hind limb ischemia/reperfusion injury in a rat model. Ren
Fail. 38:693–698. 2016. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhong K: Curcumin mediates a protective
effect via TLR-4/NF-κB signaling pathway in rat model of severe
acute pancreatitis. Cell Biochem Biophys. 73:175–180. 2015.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Ueki M, Ueno M, Morishita J and Maekawa N:
Curcumin ameliorates cisplatin-induced nephrotoxicity by inhibiting
renal inflammation in mice. J Biosci Bioeng. 115:547–551. 2013.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Zhang DM, Li YC, Xu D, Ding XQ and Kong
LD: Protection of curcumin against fructose-induced hyperuricaemia
and renal endothelial dysfunction involves NO-mediated JAK-STAT
signalling in rats. Food Chem. 134:2184–2193. 2012. View Article : Google Scholar : PubMed/NCBI
|
22
|
Zhang XH, Li ML, Wang B, Guo MX and Zhu
RM: Caspase-1 inhibition alleviates acute renal injury in rats with
severe acute pancreatitis. World J Gastroenterol. 20:10457–10463.
2014. View Article : Google Scholar : PubMed/NCBI
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Makhija R and Kingsnorth AN: Cytokine
storm in acute pancreatitis. J Hepatobiliary Pancreat Surg.
9:401–410. 2002. View Article : Google Scholar : PubMed/NCBI
|
25
|
Yu J, Deng W, Wang W, Ding Y, Jin H, Chen
C, Chen X, Xiong X and Xu S: Inhibition of poly (ADP-ribose)
polymerase attenuates acute kidney injury in sodium
taurocholate-induced acute pancreatitis in rats. Pancreas.
41:1299–1305. 2012. View Article : Google Scholar : PubMed/NCBI
|
26
|
Chuang PY and He JC: JAK/STAT signaling in
renal diseases. Kidney Int. 78:231–234. 2010. View Article : Google Scholar : PubMed/NCBI
|
27
|
Kuratsune M, Masaki T, Hirai T,
Kiribayashi K, Yokoyama Y, Arakawa T, Yorioka N and Kohno N: Signal
transducer and activator of transcription 3 involvement in the
development of renal interstitial fibrosis after unilateral
ureteral obstruction. Nephrology (Carlton). 12:565–571. 2007.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Berthier CC, Zhang H, Schin M, Henger A,
Nelson RG, Yee B, Boucherot A, Neusser MA, Cohen CD, Carter-Su C,
et al: Enhanced expression of janus kinase-signal transducer and
activator of transcription pathway members in human diabetic
nephropathy. Diabetes. 58:469–477. 2009. View Article : Google Scholar : PubMed/NCBI
|
29
|
Lu TC, Wang ZH, Feng X, Chuang PY, Fang W,
Shen Y, Levy DE, Xiong H, Chen N and He JC: Knockdown of Stat3
activity in vivo prevents diabetic glomerulopathy. Kidney Int.
76:63–71. 2009. View Article : Google Scholar : PubMed/NCBI
|
30
|
Yu JH, Kim KH and Kim H: Suppression of
IL-1beta expression by the Jak 2 inhibitor AG490 in
cerulein-stimulated pancreatic acinar cells. Biochem Pharmacol.
72:1555–1562. 2006. View Article : Google Scholar : PubMed/NCBI
|
31
|
Duan W, Yang Y, Yan J, Yu S, Liu J, Zhou
J, Zhang J, Jin Z and Yi D: The effects of curcumin post-treatment
against myocardial ischemia and reperfusion by activation of the
JAK2/STAT3 signaling pathway. Basic Res Cardiol. 107:2632012.
View Article : Google Scholar : PubMed/NCBI
|